BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kronbichler A, Lee KH, Denicolò S, Choi D, Lee H, Ahn D, Kim KH, Lee JH, Kim H, Hwang M, Jung SW, Lee C, Lee H, Sung H, Lee D, Hwang J, Kim S, Hwang I, Kim DY, Kim HJ, Cho G, Cho Y, Kim D, Choi M, Park J, Park J, Tizaoui K, Li H, Smith L, Koyanagi A, Jacob L, Gauckler P, Shin JI. Immunopathogenesis of ANCA-Associated Vasculitis. Int J Mol Sci 2020;21:E7319. [PMID: 33023023 DOI: 10.3390/ijms21197319] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan S, Wang D, Liu H, Zhang S, Yang W, Lv M, Zhou Y, Zhang S, Song J, Liu H. New drug approvals for 2021: Synthesis and clinical applications. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114898] [Reference Citation Analysis]
2 Hu X, Shen C, Meng T, Ooi JD, Eggenhuizen PJ, Zhou Y, Luo H, Chen J, Lin W, Gong Y, Xiong Q, Xu J, Liu N, Xiao X, Tang R, Zhong Y. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.991469] [Reference Citation Analysis]
3 Thu Aung Z, Oluyombo R, Karim M, Wong Sun Wai J, Ugni S. SARS-CoV-2 Infection: A Forerunner or Precursor in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Kidney Injury. Cureus 2022. [DOI: 10.7759/cureus.28705] [Reference Citation Analysis]
4 Sun K, Fisher JH, Pagnoux C. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes. Curr Rheumatol Rep 2022;24:259-67. [PMID: 35794350 DOI: 10.1007/s11926-022-01078-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhu Q, Li F, Xie X, Chen B, Yu Q, Wei Y, Ge Y. Relationship Between Gender and 1-Year Mortality in ANCA-Associated Vasculitis Patients: A Single-Center Retrospective Analysis and Meta-Analysis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.945011] [Reference Citation Analysis]
6 Ahn SS, Yoon T, Song JJ, Park YB, Lee SW. Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study. PLoS One 2022;17:e0271055. [PMID: 35797397 DOI: 10.1371/journal.pone.0271055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Molnár A, Studinger P, Ledó N. Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies. Front Med 2022;9:884188. [DOI: 10.3389/fmed.2022.884188] [Reference Citation Analysis]
8 Wojciechowicz K, Spodzieja M, Lisowska KA, Wardowska A. The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases. Cellular Immunology 2022;376:104532. [DOI: 10.1016/j.cellimm.2022.104532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang J, Xu Y, Wang G. ANCA-associated vasculitis with abdominal aortic aneurysm : Case report and literature review. Vascular 2022;:17085381221100384. [PMID: 35593219 DOI: 10.1177/17085381221100384] [Reference Citation Analysis]
10 Beketova MF, Babak VV, Suprun MD, Beketova TV, Georginova OA. On the issue of post COVID-19 condition in patients with rheumatic diseases. Naučno-praktičeskaâ revmatologiâ 2022;60:162-164. [DOI: 10.47360/1995-4484-2022-162-164] [Reference Citation Analysis]
11 Agarwal A, Rübsam A, zur Bonsen L, Pichi F, Neri P, Pleyer U. A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments. JCM 2022;11:2525. [DOI: 10.3390/jcm11092525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Dritsoula A, Dowsett L, Pilotti C, O'Connor MN, Moss SE, Greenwood J. Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway. Sci Rep 2022;12:4867. [PMID: 35318338 DOI: 10.1038/s41598-022-08516-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate Lymphoid Cells in Autoimmune Diseases. Front Immunol 2021;12:789788. [PMID: 35069567 DOI: 10.3389/fimmu.2021.789788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Fuchs S, Scheffschick A, Gunnarsson I, Brauner H. Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature. Front Immunol 2021;12:796640. [PMID: 35116030 DOI: 10.3389/fimmu.2021.796640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Essien F, Evans J, Kyle A, Urisman A, Adams N. ‘Granulomatosis with polyangiitis after Pfizer vaccination’: a case report. Therapeutic Advances in Rare Disease 2022;3:263300402211300. [DOI: 10.1177/26330040221130084] [Reference Citation Analysis]
16 李 亚. A Case of ANCA-Associated Vasculitis with Cerebral Infarction and Ulnar Nerve Damage as the Main Manifestation. ACM 2022;12:5441-5445. [DOI: 10.12677/acm.2022.126788] [Reference Citation Analysis]
17 Bayrashevskaya A, Degtyareva N, Radenska-lopovok S. ANCA-associated small-vessel vasculitides. Arkh patol 2022;84:50. [DOI: 10.17116/patol20228401150] [Reference Citation Analysis]
18 Wali HA, Tabb D, Baloch SA. Diffuse Alveolar Hemorrhage Associated With Severe Acute Respiratory Syndrome Coronavirus 2. Cureus 2021. [DOI: 10.7759/cureus.20171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hecker C, Welponer T, Herold M, Trinka E, Broussalis E, Killer-Oberpfalzer M. Update on treatment strategies for vasculitis affecting the central nervous system. Drug Discov Today 2021:S1359-6446(21)00501-8. [PMID: 34838730 DOI: 10.1016/j.drudis.2021.11.020] [Reference Citation Analysis]
20 Kronbichler A, Geetha D, Smith RM, Egan AC, Bajema IM, Schönermarck U, Mahr A, Anders HJ, Bruchfeld A, Cid MC, Jayne DRW. The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev 2021;:102986. [PMID: 34718165 DOI: 10.1016/j.autrev.2021.102986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
21 Żabińska M, Kościelska-Kasprzak K, Krajewska J, Bartoszek D, Augustyniak-Bartosik H, Krajewska M. Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease Activity. Cells 2021;10:1773. [PMID: 34359942 DOI: 10.3390/cells10071773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Ahn SS, Yoon T, Song JJ, Park YB, Lee SW. Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. In Vivo 2021;35:1761-8. [PMID: 33910860 DOI: 10.21873/invivo.12435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Müller A, Krause B, Kerstein-Stähle A, Comdühr S, Klapa S, Ullrich S, Holl-Ulrich K, Lamprecht P. Granulomatous Inflammation in ANCA-Associated Vasculitis. Int J Mol Sci 2021;22:6474. [PMID: 34204207 DOI: 10.3390/ijms22126474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
24 Hakroush S, Kluge IA, Ströbel P, Korsten P, Tampe D, Tampe B. Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis. J Clin Med 2021;10:1231. [PMID: 33809645 DOI: 10.3390/jcm10061231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
25 Beketova TV, Babak VV, Suprun MD. The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic. Naučno-praktičeskaâ revmatologiâ 2021;59:37-46. [DOI: 10.47360/1995-4484-2021-37-46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Nagano K, Tsutsumi Y. Phage Display Technology as a Powerful Platform for Antibody Drug Discovery. Viruses 2021;13:178. [PMID: 33504115 DOI: 10.3390/v13020178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]